Article
Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
Journal of gastroenterology and hepatology - 1 Apr 2010
Tsang Owen T-Y, Zee Jonpaul S-T, Chan Jacky M-C, Li Reggie S-T, Kan Yee-Man, Li Francis T-W, Lo Fu-Hang, Chow David A, Cheung Kent W-L, Chan Kam-Hon, Yeung Yat-Wah, Ng Fook-Hong, Li Michael K-K, Kwan Wai-Keung, Lai Thomas S-T
Abstract excerpt
BACKGROUND AND AIMS: Chronic hepatitis C genotype 6 is common in Hong Kong, especially among i.v. drug abusers. Responses of these patients to combination of pegylated interferon and ribavirin treatment were inconsistent and the numbers of patients involved in previous studies were small. We performed a retrospective study to compare the therapeutic responses of this regimen in patients infected with genotype 6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.